【环球网财经综合报道】日前,华宝恒生港股通创新药精选ETF公布的上市交易公告书中,披露了持有人户数、持有人结构及前十名持有人。而截至6月30日,巴克莱银行持有该ETF达2000万份,占基金总份额的4.5997%,为第一大持有人。东方IC事实上,巴克莱银行并非首次涉足创新药ETF投资。2024年底,巴克莱银行便已买入华泰柏瑞恒生创新药ETF(QDII),彼时持有份额达8500万份,占总份额的...
Source Link【环球网财经综合报道】日前,华宝恒生港股通创新药精选ETF公布的上市交易公告书中,披露了持有人户数、持有人结构及前十名持有人。而截至6月30日,巴克莱银行持有该ETF达2000万份,占基金总份额的4.5997%,为第一大持有人。东方IC事实上,巴克莱银行并非首次涉足创新药ETF投资。2024年底,巴克莱银行便已买入华泰柏瑞恒生创新药ETF(QDII),彼时持有份额达8500万份,占总份额的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.